Abstract
Cell death is a major component of developmental programs. Controlled killing of specific cells at appropriate time points is required for normal growth and shaping of organisms. However, cellular demolition can also result in a variety of pathologies that are frequently fatal, when implemented inappropriately. Delineation of cell death mechanisms has been greatly facilitated by the use of simple model organisms such as the nematode worm Caenorhabditis elegans. Research in C. elegans has proven instrumental for the elucidation of the molecular mechanisms underlying both apoptotic and necrotic cell death. Here, we introduce the C. elegans model and review the current understanding of cell death pathways in this organism. We further focus on recent studies implicating autophagy, the main cellular process for bulk protein and organelle recycling, in nematode cell death. These studies reveal that autophagic mechanisms have a prominent role in both apoptosis and necrosis. We survey the relevant findings in C. elegans and also consider the contribution of autophagy in cell death in other experimental systems. Comparative analysis suggests that the involvement of autophagy in cell death is evolutionary conserved in metazoans. Thus, interfering with the autophagic process may facilitate therapeutic intervention in human pathologies where aberrant cell death is a contributing factor.
Keywords: Apoptosis, Autophagy, Beclin, Caenorhabditis elegans, Excitotoxicity, Lysosome, Necrosis, Neurodegeneration
Current Pharmaceutical Design
Title: Autophagy and Cell Death in Caenorhabditis elegans
Volume: 14 Issue: 2
Author(s): Nektarios Tavernarakis and Chrysanthi Samara
Affiliation:
Keywords: Apoptosis, Autophagy, Beclin, Caenorhabditis elegans, Excitotoxicity, Lysosome, Necrosis, Neurodegeneration
Abstract: Cell death is a major component of developmental programs. Controlled killing of specific cells at appropriate time points is required for normal growth and shaping of organisms. However, cellular demolition can also result in a variety of pathologies that are frequently fatal, when implemented inappropriately. Delineation of cell death mechanisms has been greatly facilitated by the use of simple model organisms such as the nematode worm Caenorhabditis elegans. Research in C. elegans has proven instrumental for the elucidation of the molecular mechanisms underlying both apoptotic and necrotic cell death. Here, we introduce the C. elegans model and review the current understanding of cell death pathways in this organism. We further focus on recent studies implicating autophagy, the main cellular process for bulk protein and organelle recycling, in nematode cell death. These studies reveal that autophagic mechanisms have a prominent role in both apoptosis and necrosis. We survey the relevant findings in C. elegans and also consider the contribution of autophagy in cell death in other experimental systems. Comparative analysis suggests that the involvement of autophagy in cell death is evolutionary conserved in metazoans. Thus, interfering with the autophagic process may facilitate therapeutic intervention in human pathologies where aberrant cell death is a contributing factor.
Export Options
About this article
Cite this article as:
Tavernarakis Nektarios and Samara Chrysanthi, Autophagy and Cell Death in Caenorhabditis elegans, Current Pharmaceutical Design 2008; 14 (2) . https://dx.doi.org/10.2174/138161208783378770
DOI https://dx.doi.org/10.2174/138161208783378770 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Utility of the Electrocardiogram in Drug Overdose and Poisoning: Theoretical Considerations and Clinical Implications
Current Cardiology Reviews Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients
Current Clinical Pharmacology A Review of Maternal and Fetal Growth Factors in Diabetic Pregnancy
Current Diabetes Reviews Delivery of Large Genomic DNA Inserts > 100 kb Using HSV-1 Amplicons
Current Gene Therapy Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Investigation on the Interaction Between Anthracyclines and DNA in the Presence of Quercetin by Resonance Light Scattering Technique and Its Analytical Application
Current Analytical Chemistry Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
Anti-Cancer Agents in Medicinal Chemistry The Hepatic Lipidome: A Gateway to Understanding the Pathogenes is of Alcohol-Induced Fatty Liver
Current Molecular Pharmacology Atrial Tachycardias Arising from the Atrial Appendages and Aortic Sinus of Valsalva
Current Cardiology Reviews Cardiovascular Complications of HIV Infection and Treatment
Cardiovascular & Hematological Agents in Medicinal Chemistry Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses
Current Drug Targets - CNS & Neurological Disorders The GH/IGF-1 Axis in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Platelets in Atherothrombosis - Diagnostic and Prognostic Value of Platelet Activation in Patients with Atherosclerotic Diseases
Current Vascular Pharmacology Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Oxidative Stress and Lipid Peroxidation in Prolonged Users of Methamphetamine
Drug Metabolism Letters The Role of Matrix Metalloproteinases in Diabetes Mellitus
Current Topics in Medicinal Chemistry Impact of Pulmonary Vascular Resistances in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem
Current Cardiology Reviews Lipids, Statins and Heart Failure: An Update
Current Pharmaceutical Design